VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $94,122,000 | +45.5% | 4,049,986 | -0.4% | 0.04% | +48.3% |
Q1 2018 | $64,709,000 | -19.1% | 4,064,576 | +5.6% | 0.03% | -17.1% |
Q4 2017 | $79,973,000 | +132.8% | 3,848,622 | +60.6% | 0.04% | +118.8% |
Q3 2017 | $34,350,000 | -12.8% | 2,397,002 | +5.3% | 0.02% | -20.0% |
Q2 2017 | $39,380,000 | +36.4% | 2,276,364 | -13.0% | 0.02% | +25.0% |
Q1 2017 | $28,861,000 | -40.5% | 2,616,584 | -21.7% | 0.02% | -38.5% |
Q4 2016 | $48,493,000 | -38.7% | 3,339,752 | +3.7% | 0.03% | -42.2% |
Q3 2016 | $79,095,000 | +59.7% | 3,221,790 | +31.0% | 0.04% | +55.2% |
Q2 2016 | $49,536,000 | -55.9% | 2,459,638 | -42.4% | 0.03% | -58.0% |
Q1 2016 | $112,321,000 | -74.5% | 4,270,709 | -1.4% | 0.07% | -76.2% |
Q4 2015 | $440,130,000 | -41.5% | 4,329,849 | +2.7% | 0.29% | -48.6% |
Q3 2015 | $752,068,000 | -14.4% | 4,216,103 | +6.6% | 0.56% | -7.1% |
Q2 2015 | $878,802,000 | +6.0% | 3,955,898 | -5.2% | 0.61% | +5.0% |
Q1 2015 | $828,980,000 | +49.3% | 4,173,700 | +7.6% | 0.58% | +61.0% |
Q4 2014 | $555,207,000 | +18.5% | 3,879,589 | +8.6% | 0.36% | +12.2% |
Q3 2014 | $468,550,000 | -2.4% | 3,571,257 | -6.2% | 0.32% | -1.8% |
Q2 2014 | $479,926,000 | -7.7% | 3,805,321 | -3.5% | 0.33% | -14.4% |
Q1 2014 | $519,798,000 | +12.8% | 3,942,935 | +0.5% | 0.38% | +16.5% |
Q4 2013 | $460,685,000 | +11.0% | 3,924,073 | -1.3% | 0.33% | +2.8% |
Q3 2013 | $414,866,000 | +22.7% | 3,976,486 | +1.2% | 0.32% | +11.2% |
Q2 2013 | $338,167,000 | – | 3,928,520 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |